Y. Ying

发表

LP03 : Safety and efficacy of short-duration treatment with GS-9857 combined with sofosbuvir/GS-5816 in treatment-naïve and DAA-experienced genotype 1 patients with and without cirrhosis

E. Gane, D. Brainard, E. Svarovskaia, 2015 .